Aminotransferse Levels are not Predictive of Histologic Activity or Stage in Morbidly Obese Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)

被引:0
|
作者
Birerdinc, Aybike [1 ]
Lei, Wang [2 ]
Ozcan, Kenan [2 ]
Nguyenngo, Cartherine [2 ]
Estep, Michael [1 ]
Afendy, Arian [1 ]
Baranova, Ancha [1 ]
Younossi, Zobair [3 ]
机构
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] George Mason Univ, Coll Sci, Sch Syst Biol, Fairfax, VA 22030 USA
[3] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
294
引用
收藏
页码:S116 / S117
页数:2
相关论文
共 50 条
  • [41] Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?
    Crespo, J
    Fernández-Gil, P
    Hernández-Guerra, M
    Cayón, A
    Mayorga, M
    Domínguez-Diez, A
    Fernández-Escalante, JC
    Pons-Romero, F
    OBESITY SURGERY, 2001, 11 (03) : 254 - 257
  • [42] Sex difference in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tomiya, Tomoaki
    HEPATOLOGY RESEARCH, 2010, 40 (01) : 108 - 110
  • [43] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Sila Cocciolillo
    Giustino Parruti
    Leonardo Marzio
    World Journal of Hepatology, 2014, (07) : 496 - 503
  • [44] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245
  • [45] A National Survey of Physicians Regarding Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH): The Disease and Clinical Trial Awareness Program for NASH
    Younossi, Zobair M.
    Stepanova, Maria
    Saenz, Thomas
    Cooper, Gayle
    Schmidt, Christa
    Petruccelli, Steve
    HEPATOLOGY, 2017, 66 : 1184A - 1184A
  • [46] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Cocciolillo, Sila
    Parruti, Giustino
    Marzio, Leonardo
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 496 - 503
  • [47] PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer
    Peyrou, Marion
    Bourgoin, Lucie
    Foti, Michelangelo
    DIGESTIVE DISEASES, 2010, 28 (01) : 236 - 246
  • [48] An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (08) : 759 - 772
  • [49] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    Weiner, R. A.
    DIGESTIVE DISEASES, 2010, 28 (01) : 274 - 279
  • [50] Clinical and Metabolic Profile of Morbidly Obese Patients With Non-Alcoholic Steatohepatitis (NASH)
    Nguyenngo, Catherine T.
    Estep, J. Michael
    Stepanova, Maria
    Afendy, Mariam
    Goodman, Zachary
    Baranova, Ancha
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2012, 142 (05) : S545 - S545